Actualité
Il y a 1 mois
Un médecin virtuel pour le diagnostic des épisodes dépressifs majeurs

Les patients semblent bien accepter le fait de parler de leurs problèmes de santé à un médecin virtuel, qui présente une spécificité et une sensibilité satisfaisantes pour diagnostiquer un épisode dépressif majeur, montre une étude française. Lire la suite

Cet article Un médecin virtuel pour le diagnostic des épisodes dépressifs majeurs est apparu en premier sur Ascodocpsy.

ASCODOCPSY
Articles liés par le même flux
Presse médicale
Il y a 1 heures
ScienceDirect

Publication date: Available online 23 May 2017
Source:Médecine et Maladies Infectieuses
Author(s): P.A. Coffie, A. Patassi, A. Doumbia, G. Bado, E. Messou, A. Minga, E. Allah-Kouadio, D.M. Zannou, M. Seydi, A.R. Kakou, F. Dabis, G. Wandeler
BackgroundWe aimed to describe changes in hepatitis B screening practices over a 3-year period among HIV-infected patients in West Africa.MethodsA medical chart review was conducted in urban HIV treatment centers in Ivory Coast (3 sites), Benin, Burkina Faso, Senegal, and Togo (1 site each). Among patients who started antiretroviral treatment between 2010 and 2012, 100 per year were randomly selected from each clinic. Demographic, clinical, and laboratory data was collected using a standardized questionnaire. We assessed changes in the proportion of patients screened over time and identified predictors of screening in a multivariable logistic regression.ResultsA total of 2097 patients were included (median age: 37 years, 65.4% of women). Overall, 313 (14.9%) patients had been screened for hepatitis B, with an increase from 10.6% in 2010 to 18.9% in 2012 (P0.001) and substantial differences across countries. In multivariable analysis, being aged over 45 years (adjusted odds ratio: 1.34 [1.01–1.77]) and having an income-generating activity (adjusted odds ratio: 1.82 [1.09–3.03]) were associated with screening for hepatitis B infection. Overall, 62 HIV-infected patients (19.8%, 95% confidence interval: 15.5–24.7) were HBsAg-positive and 82.3% of them received a tenofovir-co[...]

Presse médicale
Il y a 1 heures
ScienceDirect

Publication date: Available online 22 May 2017
Source:Médecine et Maladies Infectieuses
Author(s): S. Mouline, H. Naoui, F. Nachite, M. Oukabli, M. Laroussi, A. Zentar, B. Lmimouni


Presse médicale
Il y a 1 heures
ScienceDirect

Publication date: Available online 23 May 2017
Source:Médecine et Maladies Infectieuses
Author(s): P.A. Coffie, A. Patassi, A. Doumbia, G. Bado, E. Messou, A. Minga, E. Allah-Kouadio, D.M. Zannou, M. Seydi, A.R. Kakou, F. Dabis, G. Wandeler
BackgroundWe aimed to describe changes in hepatitis B screening practices over a 3-year period among HIV-infected patients in West Africa.MethodsA medical chart review was conducted in urban HIV treatment centers in Ivory Coast (3 sites), Benin, Burkina Faso, Senegal, and Togo (1 site each). Among patients who started antiretroviral treatment between 2010 and 2012, 100 per year were randomly selected from each clinic. Demographic, clinical, and laboratory data was collected using a standardized questionnaire. We assessed changes in the proportion of patients screened over time and identified predictors of screening in a multivariable logistic regression.ResultsA total of 2097 patients were included (median age: 37 years, 65.4% of women). Overall, 313 (14.9%) patients had been screened for hepatitis B, with an increase from 10.6% in 2010 to 18.9% in 2012 (P0.001) and substantial differences across countries. In multivariable analysis, being aged over 45 years (adjusted odds ratio: 1.34 [1.01–1.77]) and having an income-generating activity (adjusted odds ratio: 1.82 [1.09–3.03]) were associated with screening for hepatitis B infection. Overall, 62 HIV-infected patients (19.8%, 95% confidence interval: 15.5–24.7) were HBsAg-positive and 82.3% of them received a tenofovir-co[...]

Presse médicale
Il y a 1 heures
ScienceDirect

Publication date: Available online 27 April 2017
Source:Annales d'Endocrinologie
Author(s): Albert Beckers, Liliya Rostomyan, Iulia Potorac, Pablo Beckers, Adrian F. Daly
X-linked acrogigantism (XLAG) is a new, pediatric-onset genetic syndrome, due to Xq26.3 microduplications encompassing the GPR101 gene. XLAG has a remarkably distinct phenotype with disease onset occurring before the age of 5 in all cases described to date, which is significantly younger than in other forms of pituitary gigantism. These patients have mixed GH and prolactin positive adenomas and/or mixed-cell hyperplasia and highly elevated levels of GH/IGF-1 and prolactin. Given their particularly young age of onset, the[...]

Presse médicale
Il y a 1 heures
ScienceDirect

Publication date: Available online 5 May 2017
Source:Annales d'Endocrinologie
Author(s): Liliya Rostomyan, Iulia Potorac, Pablo Beckers, Adrian F. Daly, Albert Beckers
AIP mutations are rare in sporadic acromegaly but they are seen at a higher frequency among certain specific populations of pituitary adenoma patients (pituitary gigantism cases, familial isolated pituitary adenoma (FIPA) kindreds, and patients with macroadenomas who are diagnosed ≤30 years). AIP mutations are most prevalent in patients with pituitary gigantism (29% of this group were found to have mutations in AIP gene). These data support targeted genetic screening for AIP mutations/deletions in these groups of pituitary [...]

Presse médicale
Il y a 1 heures
ScienceDirect

Publication date: Available online 4 May 2017
Source:Annales d'Endocrinologie
Author(s): Maïthé Tauber
Approximately 10% of small for gestational age (SGA) children maintain a small body size throughout childhood and often into adult life with a decreased pubertal spurt. Growth hormone (GH) therapy increases short-term growth in a dose–dependent manner and adult height had now been well documented. Shorter children might benefit from a higher dose at start (50μg/kg/day). The response to GH treatment was similar for both preterm and term short SGA groups and the effect of GH treatment on adult height showed a wide variation in growth response. As a whole, mean adult height is higher than −[...]